Earnings Feed
Start Free
Home/Filings/4/0001209191-06-066822
4//SEC Filing

QUESTCOR PHARMACEUTICALS INC 4

Accession 0001209191-06-066822

CIK 0000891288operating
View on SEC.govCompany Profile

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 4:06 PM ET

Size

31.6 KB

Accession

0001209191-06-066822

Insider Transaction Report

Form 4
Period: 2006-12-20
QUESTCOR PHARMACEUTICALS INCQSC
CAVAZZA PAOLO
10% Owner
Transactions
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+4,321,699$6,482,549→ 4,321,699 total(indirect: Shares directly held by Inverlochy Consultadoria & Servicos L.d.A.)
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+379,747$569,621→ 4,801,445 total(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−379,746$569,619→ 0 total(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+4,321,698$6,482,547→ 4,421,698 total(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal L.d.A.)
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+379,746$569,619→ 4,701,445 total(indirect: Shares directly held by Inverlochy Consultadoria & Servicos L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−4,321,698$6,482,547→ 4,321,699 total
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−379,747$569,621→ 379,746 total(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−4,321,699$6,482,549→ 0 total
Holdings

  • Common Stock, no par value per share

    (indirect: Shares directly held by Claudio Cavazza)
    1,756,781

  • Common Stock, no par value per share

    (indirect: Shares directly held by Aptafin S.p.A.)
    549,100

  • Common Stock, no par value per share

    (indirect: Shares directly held by Paolo Cavazza)
    2,446,782
DEFIANTE FARMACEUTICA LDA
10% Owner
Transactions
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+4,321,698$6,482,547→ 4,421,698 total(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal L.d.A.)
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+4,321,699$6,482,549→ 4,321,699 total(indirect: Shares directly held by Inverlochy Consultadoria & Servicos L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−4,321,698$6,482,547→ 4,321,699 total
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−379,746$569,619→ 0 total(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−4,321,699$6,482,549→ 0 total
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+379,746$569,619→ 4,701,445 total(indirect: Shares directly held by Inverlochy Consultadoria & Servicos L.d.A.)
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+379,747$569,621→ 4,801,445 total(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−379,747$569,621→ 379,746 total(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
Holdings

  • Common Stock, no par value per share

    (indirect: Shares directly held by Claudio Cavazza)
    1,756,781

  • Common Stock, no par value per share

    (indirect: Shares directly held by Aptafin S.p.A.)
    549,100

  • Common Stock, no par value per share

    (indirect: Shares directly held by Paolo Cavazza)
    2,446,782
APTAFIN S P A
10% Owner
Transactions
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+4,321,698$6,482,547→ 4,421,698 total(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−379,747$569,621→ 379,746 total(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+4,321,699$6,482,549→ 4,321,699 total(indirect: Shares directly held by Inverlochy Consultadoria & Servicos L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−4,321,698$6,482,547→ 4,321,699 total
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−4,321,699$6,482,549→ 0 total
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+379,747$569,621→ 4,801,445 total(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal L.d.A.)
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+379,746$569,619→ 4,701,445 total(indirect: Shares directly held by Inverlochy Consultadoria & Servicos L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−379,746$569,619→ 0 total(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
Holdings

  • Common Stock, no par value per share

    (indirect: Shares directly held by Claudio Cavazza)
    1,756,781

  • Common Stock, no par value per share

    (indirect: Shares directly held by Paolo Cavazza)
    2,446,782

  • Common Stock, no par value per share

    (indirect: Shares directly held by Aptafin S.p.A.)
    549,100
SIGMA TAU INTERNATIONAL SA
10% Owner
Transactions
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+4,321,699$6,482,549→ 4,321,699 total(indirect: Shares directly held by Inverlochy Consultadoria & Servicos L.d.A.)
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+379,746$569,619→ 4,701,445 total(indirect: Shares directly held by Inverlochy Consultadoria & Servicos L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−4,321,698$6,482,547→ 4,321,699 total
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−379,746$569,619→ 0 total(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−4,321,699$6,482,549→ 0 total
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+4,321,698$6,482,547→ 4,421,698 total(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal L.d.A.)
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+379,747$569,621→ 4,801,445 total(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−379,747$569,621→ 379,746 total(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
Holdings

  • Common Stock, no par value per share

    (indirect: Shares directly held by Aptafin S.p.A.)
    549,100

  • Common Stock, no par value per share

    (indirect: Shares directly held by Paolo Cavazza)
    2,446,782

  • Common Stock, no par value per share

    (indirect: Shares directly held by Claudio Cavazza)
    1,756,781
CAVAZZA CLAUDIO
10% Owner
Transactions
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−4,321,698$6,482,547→ 4,321,699 total
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+379,746$569,619→ 4,701,445 total(indirect: Shares directly held by Inverlochy Consultadoria & Servicos L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−379,746$569,619→ 0 total(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−4,321,699$6,482,549→ 0 total
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+4,321,698$6,482,547→ 4,421,698 total(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal L.d.A.)
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+4,321,699$6,482,549→ 4,321,699 total(indirect: Shares directly held by Inverlochy Consultadoria & Servicos L.d.A.)
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+379,747$569,621→ 4,801,445 total(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−379,747$569,621→ 379,746 total(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
Holdings

  • Common Stock, no par value per share

    (indirect: Shares directly held by Claudio Cavazza)
    1,756,781

  • Common Stock, no par value per share

    (indirect: Shares directly held by Paolo Cavazza)
    2,446,782

  • Common Stock, no par value per share

    (indirect: Shares directly held by Aptafin S.p.A.)
    549,100
Inverlochy Consultadoria & Servicos L.D.A.
10% Owner
Transactions
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+4,321,698$6,482,547→ 4,421,698 total(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−379,746$569,619→ 0 total(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+379,746$569,619→ 4,701,445 total(indirect: Shares directly held by Inverlochy Consultadoria & Servicos L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−4,321,699$6,482,549→ 0 total
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−4,321,698$6,482,547→ 4,321,699 total
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+379,747$569,621→ 4,801,445 total(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−379,747$569,621→ 379,746 total(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+4,321,699$6,482,549→ 4,321,699 total(indirect: Shares directly held by Inverlochy Consultadoria & Servicos L.d.A.)
Holdings

  • Common Stock, no par value per share

    (indirect: Shares directly held by Claudio Cavazza)
    1,756,781

  • Common Stock, no par value per share

    (indirect: Shares directly held by Paolo Cavazza)
    2,446,782

  • Common Stock, no par value per share

    (indirect: Shares directly held by Aptafin S.p.A.)
    549,100
Chaumiere Consultadoria & Servicos SDC Unipessoal LDA
10% Owner
Transactions
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−379,747$569,621→ 379,746 total(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+4,321,698$6,482,547→ 4,421,698 total(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−4,321,699$6,482,549→ 0 total
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+379,747$569,621→ 4,801,445 total(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal L.d.A.)
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+379,746$569,619→ 4,701,445 total(indirect: Shares directly held by Inverlochy Consultadoria & Servicos L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−379,746$569,619→ 0 total(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+4,321,699$6,482,549→ 4,321,699 total(indirect: Shares directly held by Inverlochy Consultadoria & Servicos L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−4,321,698$6,482,547→ 4,321,699 total
Holdings

  • Common Stock, no par value per share

    (indirect: Shares directly held by Paolo Cavazza)
    2,446,782

  • Common Stock, no par value per share

    (indirect: Shares directly held by Claudio Cavazza)
    1,756,781

  • Common Stock, no par value per share

    (indirect: Shares directly held by Aptafin S.p.A.)
    549,100
SIGMA TAU FINANZIARIA SPA
10% Owner
Transactions
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−379,746$569,619→ 0 total(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−4,321,698$6,482,547→ 4,321,699 total
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+379,746$569,619→ 4,701,445 total(indirect: Shares directly held by Inverlochy Consultadoria & Servicos L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−4,321,699$6,482,549→ 0 total
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+4,321,698$6,482,547→ 4,421,698 total(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal L.d.A.)
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+4,321,699$6,482,549→ 4,321,699 total(indirect: Shares directly held by Inverlochy Consultadoria & Servicos L.d.A.)
  • Sale

    Common Stock, no par value per share

    2006-12-20$1.50/sh−379,747$569,621→ 379,746 total(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
  • Purchase

    Common Stock, no par value per share

    2006-12-20$1.50/sh+379,747$569,621→ 4,801,445 total(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal L.d.A.)
Holdings

  • Common Stock, no par value per share

    (indirect: Shares directly held by Claudio Cavazza)
    1,756,781

  • Common Stock, no par value per share

    (indirect: Shares directly held by Paolo Cavazza)
    2,446,782

  • Common Stock, no par value per share

    (indirect: Shares directly held by Aptafin S.p.A.)
    549,100
Footnotes (1)
  • [F1]Sigma-Tau Finanziaria S.p.A. owns 100% of the capital stock of Sigma-Tau International S.A. (f/k/a Sigma-Tau Finance Holding S.A.) and 58% of the capital stock of Defiante Farmaceutica L.d.A. Sigma-Tau International S.A. owns 42% of the capital stock of Defiante Farmaceutica L.d.A. Claudio Cavazza owns, directly and indirectly, 57% of Sigma-Tau Finanziaria S.p.A. and Paolo Cavazza owns, directly and indirectly, 38% of Sigma-Tau Finanziaria S.p.A. Paolo Cavazza and members of his family also own, directly and indirectly, 100% of Aptafin S.p.A. Aptafin S.p.A. owns, directly and indirectly, 100% of Chaumiere - Consultadoria & Servicos SDC Unipessoal L.d.A. Claudio Cavazza owns, directly and indirectly, 100% of Inverlochy Consultadoria & Servicos L.d.A. Each of the reporting persons disclaims beneficial ownership of the securities included on this report except to the extent of such person's pecuniary interest therein.

Documents

1 file

Issuer

QUESTCOR PHARMACEUTICALS INC

CIK 0000891288

→
Entity typeoperating
IncorporatedCA

Related Parties

1
  • filerCIK 0000891288

Filing Metadata

Form type
4
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 4:06 PM ET
Size
31.6 KB
View on SEC.gov